Incretins Update: A Holistic Approach to Patients With Type 2 Diabetes and Cardiometabolic Comorbidities

In this concise Medical Minute video, become familiar with incretins and review how currently available GLP-1 receptor agonists target multiple pathophysiologic defects in T2D.

Carol Hatch Wysham, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Registered Dietitians/Dietetic Technicians, Registered: maximum of 0.25 CPEU(s) Released: August 9, 2021 Expired: No longer available for credit

Learn about endogenous incretins, their downstream effects, and role in type 2 diabetes.

Carol Hatch Wysham, MD Released: August 9, 2021

A brief history of the discovery of incretins and how incretin-based therapies revolutionized modern diabetes care.

Carol Hatch Wysham, MD Released: August 13, 2021